Cardiac pressure overload initiates a systemic stem cell response

Amanda Finan1, Matthew Kiedrowski, Benjamin A Turturice

  • 1Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Cytotherapy
|May 26, 2012
PubMed

Insights

Cardiac pressure overload triggers a systemic stem cell response. Endothelial progenitor cells (EPCs) and SSEA-1(+) cells mobilize to the heart, indicating a coordinated repair mechanism.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Acute cardiac injury activates resident and non-cardiac stem cells.
  • Cardiac pressure overload (PO) is a significant stressor impacting cardiac repair mechanisms.

Purpose of the Study:

  • To define the pattern of peripheral stem cell and cardiac stem cell (CSC) activation following acute cardiac pressure overload.
  • To investigate the systemic and local stem cell responses to transaortic constriction (TAC).

Main Methods:

  • Pressure overload was induced in mice via transaortic constriction (TAC).
  • Cardiac stem cells (CSCs), endothelial progenitor cells (EPCs), hematopoietic stem cells (HSCs), and stage-specific embryonic antigen (SSEA)-1(+) cells were analyzed in the heart, spleen, and bone marrow using flow cytometry.

Main Results:

  • A systemic stem cell response involving EPCs and SSEA-1(+) cells was observed, with increased levels in the heart post-TAC.
  • Local SSEA-1(+) cell proliferation in the heart preceded increased myocardial stem cell numbers; however, EPC and CSC proliferation in the heart was not significant.
  • Systemic response included biphasic loss of splenic SSEA-1(+) cells and decreased bone marrow/spleen EPCs, with proliferation occurring after local depletion.

Conclusions:

  • An orchestrated systemic stem cell response, particularly involving EPCs and SSEA-1(+) cells, occurs in response to TAC.
  • Increased SSEA-1(+) cells and EPCs in the heart post-pressure overload likely result from both local proliferation and systemic recruitment.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...